BRCA2 Mutation Clinical Trials in Houston, Texas
2 recruitingHouston, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Breast CancerOvarian CancerEndometrial Cancer+8 more
858 Therapeutics, Inc.120 enrolled14 locationsNCT06395519
Recruiting
Not Applicable
FaCT Trial (Facilitated Cascade Testing Trial)
BRCA1 MutationBRCA2 Mutation
Weill Medical College of Cornell University820 enrolled3 locationsNCT04613440